Pfizer Ventures (US) LLC, 10% Owner at Cortexyme, Inc. (CRTX), bought 265,697 shares at $17.00 ($850K) on 2019-05-13, disclosed to the SEC on 2019-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 215,697 | $0 | 0.0% |
| 2 | $17.00 | 50,000 | $850K | 100.0% |
| Total | $3.20 avg | 265,697 | $850K | 100% |